The Renaissance Healthcare IPO Index is designed to capture the performance of newly public companies that provide healthcare products and services. Continual scientific discoveries, coupled with advancements in technology and projected increases in government spending for the aging baby boomers have established healthcare as an essential sector for those seeking leading edge investments that benefit from growing demand in this sector.

The Renaissance Healthcare IPO Index includes medical device makers, biotechnology and pharmaceutical firms, providers of healthcare products and services and health insurance companies. Novelty drugs and devices often become known to the public first through the IPO market; this enables the Renaissance Healthcare IPO Index to capture the performance of these innovative healthcare ideas at the earliest stage available to public investors.